Advertisement

Topics

C.R. Bard, Inc. Company Profile

14:26 EST 20th November 2018 | BioPortfolio


News Articles [10 Associated News Articles listed on BioPortfolio]

C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 31052018] Prices from USD $350

C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report i...

Becton, Dickinson's Dividend Continues To Grow Post C.R. Bard Acquisition

Shakespeare on palliative care

In his lifetime, William Shakespeare wrote almost 120,000 lines and about 900,000 words. His 37 plays and 154 sonnets burnished his reputation as the unrivaled wordsmith of the English language. So wh...

Global Polyethylene Glycol Market Status and Outlook 20182025 [Report Updated: 13082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Hill-Rom Provides Update On Puerto Rico Facility

CHICAGO , Oct. 11, 2017 /- Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided an update on its Aspen Surgical facility in Las Piedras, Puerto Rico , where the company manufactur...

Guest Article: How to sell your EHR and other health IT products into clinics and physician practices

A frequent question I am asked by startups and new product development teams (especially those building EMRs / EHRs) is “what’s the best way to sell my EHR to doctors and clinics?” M...

Guest Article: How to sell your health IT products into hospitals

One of the most frequent questions I am asked by startups and new product development teams is “what’s the best way to sell my X product into a hospital?” It’s a terrific quest...

C. R. Bard Inc Medical Equipment Deals and Alliances Profile [Report Updated: 24042018] Prices from USD $250

SummaryC. R. Bard Inc Bard, a subsidiary of Becton Dickinson and Co, is a medical device company, which offers medical, surgical, diagnostic and patient care devices related to vascular disorders, uro...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Cordran [Watson Pharma, Inc.]

Cordran® Tape Flurandrenolide Tape, USP For the Physician Rx only Revised: May 2010

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Two-Stage Exchange and Marlex-Mesh Reconstruction for Infection with Extensor Mechanism Disruption After Total Knee Arthroplasty.

Periprosthetic joint infection (PJI) of the knee with concurrent disruption of the extensor mechanism is a devastating complication. Historically, knees with such complications have been salvaged with...

Evaluation of a Magnetic Tracking and Electrocardiogram-based Tip Confirmation System for Peripherally Inserted Central Catheters in Pediatric Patients.

The purpose of this study was to investigate whether a magnetic tracking and electrocardiogram-based tip confirmation system (TCS) (Sherlock 3CG Tip Confirmation System; Bard, Covington, GA) permits s...

Clinical Trials [22 Associated Clinical Trials listed on BioPortfolio]

Study Of Hernia Repair Utilizing The Bard Ventrio Hernia Patch

This study will collect data on patients undergoing hernia repair using the Bard Ventrio Hernia Patch. The study will evaluate hernia recurrence rates, operating time, quality of life and...

Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent System

The medical device being examined in this study is the Bard® LifeStent® 5F Vascular Stent System. It is intended for use in patients who suffer from peripheral artery disease (PAD). PAD ...

A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries

To assess the safety and efficacy of the BARD LTX DCB for treatment of stenosis or occlusion of the superficial femoral and popliteal arteries.

Safety and Efficacy of Midline and PICC

The purpose of this study is to assess the non-inferiority for safety and efficacy of using Midline in comparison with PICC for intravenous therapy that do not require a central catheter.

The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent

This study will look at the performance of the Cordis S.M.A.R.T.™ CONTROL ™ Nitinol Stent System for the treatment of TASC C & D superficial femoral artery long lesions (up to 22 cm) i...

Companies [13 Associated Companies listed on BioPortfolio]

CR Bard

C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialt...

C. R. Bard, Inc

C. R. Bard, Inc. is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialt...

BISNAR | CHASE

The BISNAR | CHASE Orange County, California Bard Avaulta Mesh Lawyers represent people who have been very seriously injured or lost a family member due to defective products such...

C.R. Bard, Inc.

Bard Peripheral Vascular OEM Products

More Information about "C.R. Bard, Inc." on BioPortfolio

We have published hundreds of C.R. Bard, Inc. news stories on BioPortfolio along with dozens of C.R. Bard, Inc. Clinical Trials and PubMed Articles about C.R. Bard, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of C.R. Bard, Inc. Companies in our database. You can also find out about relevant C.R. Bard, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record